Superior Grade Biomass
Full Spectrum CBD Oil
Instadose Pharma cultivates large quantities of superior grade cannabis biomass, which is processed into EU-GMP Certified pharmaceutical grade cannabis oil.
Instadose Pharma cultivates large quantities of superior grade cannabis biomass that is an ideal raw material to produce EU-GMP Certified pharmaceutical grade cannabis oil. Once processed, this high-quality CBD oil is marketable as a specialty API (active pharmaceutical ingredient) and can be used to make an array of medicinal products to treat multiple ailments.
Extracting oil from cannabis has been done for centuries – but not on a commercial scale.
The challenge facing today’s medical cannabis industry is how to produce this anointed oil consistently, on a large commercial scale.
We ensure that:
- a) we produce a consistent quality oil that meets the requirements of the pharmaceutical industry and
- b) the same chemical consistency of every batch
After many years of research and development, the Instadose Pharma team has successfully met this challenge and, through our EU-GMP certified processing facility, we have perfected a method of large-scale extraction that will revolutionize the industry.
Our world class technical team has leveraged the efficacy of extraction with unique engineering and chemistry to successfully improve the cannabinoid output-to-biomass ratio and nameplate output to capital ratio. This approach combined with a scalable infrastructure provides the quality, flexibility and a competitive economical advantage in a market of ever-increasing demand and tightening margins.
Our proprietary method permits Instadose Pharma to product cannabis oil that:
- Meets EU-GMP requirements
- Avoids the use of pressure vessels at high pressure
- Reduces operating costs
Our unique extraction process avoids the scale up issues associated with other widespread methods such as supercritical carbon dioxide, butane extraction, bubble hash or rosin presses. In short, we can produce and manufacture a higher quality and quantity of CDB oil.
To meet the demands of large-scale commercial production, Instadose Pharma has furnished our facility with multiple units of custom-made state of the art processing equipment imported directly from trusted Canadian sources.
We are capable of a wide range of processes that enable production on an enormous scale at highly efficient timelines. This configuration, in addition to the enormous amount of raw material, enables us to manufacture exceedingly large amounts of product faster than any other distributor.
In addition, all our products are further supported by comprehensive onsite analytical services, in-house technicians and expert laboratory facilities that ensure the smooth operation from start to finish. Our objective is to be a reliable manufacturer who can distribute large volumes of high-grade pharmaceutical / medical grade products through a seamless process so we can meet all our contractual obligations as promised.
Good Manufacturing Practice (GMP) is a system for ensuring that products are consistently produced and controlled according to internationally accepted quality standards.
The GMP designation is designed to minimize the risks involved in any pharmaceutical production that cannot be eliminated through testing the final product. GMP covers all aspects of production from the starting materials, premises, operational and equipment to the training and personal hygiene of staff. Detailed written procedures are essential for each process that could affect the quality of the finished product. There must be systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process – every time a product is made.
EU-GMP certification is an enhancement to the GMP certification as required for the European Union countries. Instadose Pharma, as a conscientious and reputable corporation, offers full EU-GMP certified products that are cultivated, processed and distributed in accordance with these high-level standards.